Corrections  by unknown
Corrections
In the article entitled “The Endothelin-Converting Enzyme-1/
Endothelin-1 Pathway Plays a Critical Role in Inflammation-
Associated Premature Delivery in a Mouse Model” (Volume
173, pages 1077–1084 of the October 2008 issue of The
American Journal of Pathology), the second author’s name
was spelled incorrectly. The correct spelling is Haoting Yen.
In the article entitled “The Krebs Cycle and Mitochon-
drial Mass Are Early Victims of Endothelial Dysfunction:
Proteomic Approach” (Volume 174, pages 34–43 of the
January 2009 issue), two authors’ names were spelled
incorrectly. The correct spellings are Anna Csiszar and
Boris Krasnikov.
In the article entitled, “Muscleblind-Like Proteins: Sim-
ilarities and Differences in Normal and Myotonic Dystro-
phy Muscle” (Volume 174, pages 216–227 of the January
2009 issue), the production quality of Figure 4, page 222,
and Figure 6, page 223, was impaired. The corrected
figures and legends should have appeared as shown:
Figure 4. Changes in subcellular distribution of MBNL1 and MBNL2 during
myoblast culture. Normal human myoblasts were grown on coverslips for var-
ious times before fixation with formalin, permeabilization with Triton X-100, and
development with MB1a or MB2a mAbs, as described in the Materials and
Methods. At day 1, the growth medium was changed to differentiation medium.
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In the article entitled, “The Chemokine Receptor CXCR4
and theMetalloproteinaseMT1-MMPAreMutually Required
duringMelanomaMetastasis to Lungs” (Volume 174, pages
602–612 of the February 2009 issue), the production quality
of Figure 5 panel D, page 608, was impaired. The corrected
figure and legend should have appeared as shown:
Figure 6. Higher levels of MBNL2 in regener-
ating muscle fibers in a skeletal muscle biopsy
from a Duchenne muscular dystrophy patient.
Five regenerating fibers were identified by im-
munostaining with MHCn mAb (Novocastra,
Newcastle, UK; 1:20) against neonatal myosin
(A–C). In a serial section (D–F), nuclei in the
regenerating fibers were more strongly stained
for MBNL2 than nuclei in mature fibers (MB2a
mAb; 1:4). The center panels show ethidium
bromide staining of nuclei and the right panels
are merged images. In (F), MBNL2 staining is
indicated by horizontal white arrows in the
nuclei of regenerating fibers and by vertical
white arrows in the nuclei of mature fibers.
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Figure 5. Rac-Erk1/2 signaling controls up-reg-
ulation by CXCL12 of MT1-MMP expression. A:
Cells were incubated for 24 hours with CXCL12
in the absence (control) or presence of LY (20
mol/L) or UO126 (5 mol/L), and tested with
Western blot analyses for MT1-MMP expression.
BLM melanoma cells were transfected with con-
trol or Rac1 siRNA (B), or with GFP-fused wild-
type (wt) or constitutively activated (CA) forms
of Rac (C). Transfectants were subsequently in-
cubated for 24 hours with CXCL12 and subjected
to Western blotting for expression of MT1-MMP,
phospho-Erk1/2, total Erk1/2, and Rac1. D:
Transfectants expressing Rac wt or Rac CA
were subjected to Matrigel invasion assays to-
ward CXCL12, in the absence or presence of
UO126 and control or anti-MT1-MMP mAb
(left). Supernatants from these invasions were
tested by gelatinolytic zymography for MMP-2
activity (right).
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